Migration notice:
On August 9th, 2025, Finsight.com market data will be renamed and migrated to CreditFlow, a more intuitive, comprehensive and accessible market data platform for all credit products.
Contact us
for more information.
Market Data
Pricing
Solutions
Log In
Market Overview
Parent Companies
HBM BioVentures AG
HBM BioVentures AG
ABS
HYC
IGC
APAC
EMEA
LATM
USOA
Issuers
TTM
Issuers
Rating Agencies
Underwriters
View League Tables
To view dynamic league tables of the top Issuers, Rating Agencies and Underwriters, please log in or create a free Finsight.com account.
Log In
HBMN
HBM Healthcare Investments AG
5
May 29, 1996
1 to 1 of 1
New Issue Deal Count
Volume
Count
Month
Quarter
Year
Stacked
Grouped
Commentary
Upgrade Plan
Deal Flow
Upgrade Plan
Recent New Issue
Pulled
In Market
Priced
C/P
Sector
Status
Deal Name
Parent
Leads
Region
Date
HYC
HLTH
PRCD
HBMN 2021-1 (CHF 100m)
HBM BioVentures AG
HLV
,
RBI
EMEA
Jun 16, 2021
CCY
SIZE (M)
TNR
MTY
RNK
MO
SP
FI
TYPE
BNCH
IPT
GDNC
SPRD
CPN
NIC
PRICE
XKP
767.000
7
Apr-18
Ej. Xewoeajof
UV
KH
-
Tlvit
Xvyqs
1.125-1.625%
1.125%
143.75
1.13%
-
447.00000
Tranche Comments
6 ys: Comments: DHE100g 6ri mei qemur lqdjpr. WT/WT. Tupee/Hujuui. Klm llue 1.125%/1.625% (CK+145/+195, KJTOW+151.3/201.3). Kpmu mui 100g 1.125% rle, CK+143.75 / KJTOW+150;
B&I
BWICS & Inventory
This module is available on the Professional plan.
Learn more
Upgrade Plan
TRACE
This module is available on the Professional plan.
Learn more
Upgrade Plan
Research
Log In
Missing something? Tell us.